Recreational ketamine use has increased in the United States in recent years, outpacing its rise as a treatment for ...

Johnson & Johnson has announced that the U.S. Food and Drug Administration has approved Spravato (esketamine) CIII nasal ...

A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...

TITUSVILLE, N.J. - Johnson & Johnson (NYSE:JNJ) has received approval from the U.S. Food and Drug Administration (FDA) for SPRAVATO® (esketamine) nasal spray as a standalone treatment for adults with ...

Spravato is now the first-ever standalone therapy for treatment-resistant depression, and is on its way to becoming a blockbuster product.

NHS England data shows 67,794 people began receiving employment advice through the NHS talking therapies programme last year, compared to 41,907 in the previous 12 months ...

Emerging research in mental health is showing how little we know and thus how much work needs to be done, including in how ...

While the fruit has many benefits, avoid eating it to prevent putting your health at risk if you take the medication ...

The medicines may not only suppress appetite but also help curb alcoholism and other addictions. Read more at straitstimes.com.

As if we needed any more reason to ruminate over our own stresses or the world’s troubles, January 20 (today) is Blue Monday ...